VanEck Biotech ETF (NASDAQ:BBH) Sees Strong Trading Volume – Here’s Why

VanEck Biotech ETF (NASDAQ:BBH) shares saw unusually-strong trading volume on Friday. 8,876 shares traded hands during trading, an increase of 13% from the average daily volume of 7,824 shares. The stock last traded at $252.8930 and had previously closed at $251.01.

VanEck Biotech ETF Stock Up 1.1%

The firm’s fifty day moving average is $242.11 and its 200-day moving average is $208.06.

Institutional Investors Weigh In On VanEck Biotech ETF

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Nwam LLC acquired a new stake in shares of VanEck Biotech ETF in the 2nd quarter valued at about $18,614,000. Ascent Advisors LLC acquired a new position in VanEck Biotech ETF in the first quarter worth about $11,178,000. LGL Partners LLC bought a new stake in VanEck Biotech ETF in the second quarter valued at about $2,298,000. Proficio Capital Partners LLC acquired a new stake in VanEck Biotech ETF during the second quarter valued at approximately $5,183,000. Finally, Segall Bryant & Hamill LLC bought a new position in VanEck Biotech ETF during the 1st quarter worth approximately $881,000. Institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.